Zobrazeno 1 - 10
of 46
pro vyhledávání: '"T. V. Martyniuk"'
Autor:
E. G. Valeeva, T. V. Martyniuk, K. P. Ivanov, V. B. Sergienko, S. N. Nakonechnikov, I. Ye. Chazova
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 18-24 (2016)
SUMMERY According to the Russian data 34% of patients with pulmonary hypertension (PH) have complaints of chest pain. Currently, the cause of this symptoms can be as coronary heart disease, compression of the coronary arteries (usually the left main
Externí odkaz:
https://doaj.org/article/4a27a80984c34365a8aa558bb0838adc
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 1, Pp 6-12 (2011)
Pulmonary hypertension (PH) is the group of diseases characterized by progressive increase of pulmonary vascular resistance leading to right heart failure and premature death of patients. This review represents the modern clinical and functional clas
Externí odkaz:
https://doaj.org/article/8f1a5d78ba72474aa5ec7b299bae0454
Publikováno v:
Неонатологія, хірургія та перинатальна медицина, Vol 5, Iss 3(17) (2015)
Мета роботи – вивчити і проаналізувати морфологічні відмінності шлунково-кишкових перфорацій у нов онароджених. Матеріали та методи. У
Externí odkaz:
https://doaj.org/article/94316e292752444985f7108885cd5474
Publikováno v:
Системные гипертензии, Vol 14, Iss 1, Pp 45-50 (2017)
Introduction. Combination therapy is widely used in treatment of patients with arterial hypertension (AH) of high and very high cardiovascular risk. Fixed combinations (FC) of medications are preferable and it is important to develop new effective an
Externí odkaz:
https://doaj.org/article/51f54466654c4ec1815001adcc4d02ec
Autor:
T V Martyniuk, I E Chazova
Publikováno v:
Системные гипертензии, Vol 13, Iss 2, Pp 46-64 (2016)
Significant progress in the treatment of pulmonary arterial hypertension (PAH), in recent years, is associated with the introduction into clinical practice of a number of drugs pathogenetic action, can cause vasodilation and reverse remodeling of pul
Externí odkaz:
https://doaj.org/article/bb5c1970eade4a0a9eed2ac3f54e3470
Autor:
I E Chazova, T V Martyniuk
Publikováno v:
Системные гипертензии, Vol 13, Iss 2, Pp 6-10 (2016)
In the modern therapy of arterial hypertension (AH) along with thiazide diuretics b-blockers, calcium antagonists, angiotensin converting enzyme inhibitors and angiotensin receptor blockers are considered for initial and maintenance of antihypertensi
Externí odkaz:
https://doaj.org/article/dc1fc783c0634844b8d07687f8e95f97
Publikováno v:
Системные гипертензии, Vol 13, Iss 1, Pp 34-38 (2016)
The objective: to identify pathognomonic symptoms and signs of different groups of pulmonary hypertension (PH), analyze the possibility of early diagnosis of patients with PH and the validity of the questionnaire.Material and methods. The questionnai
Externí odkaz:
https://doaj.org/article/e7e12cea5d114a0a9ae24f11cee922fd
Autor:
O A Arkhipova, T V Martyniuk, E G Valeeva, G V Ryabykina, L E Samoylenko, V B Sergienko, I E Chazova
Publikováno v:
Системные гипертензии, Vol 12, Iss 4, Pp 52-56 (2015)
The precordial region. Pain in the chest in these patients is associated with relative coronary insufficiency due to low cardiac output, a relatively weak development of coronary collaterals on the background of hypertrophy of the wall of the right v
Externí odkaz:
https://doaj.org/article/842a9dd4059b4b849ebe38b4f86ab507
Publikováno v:
Системные гипертензии, Vol 12, Iss 3, Pp 50-55 (2015)
Over the last decade, the interest in the treatment of idiopathic pulmonary hypertension (IPAH) has greatly increased because of the development and implementation of innovative therapeutic approaches. One of the modern drug groups for the treatment
Externí odkaz:
https://doaj.org/article/a4adb9670b7a4d5f85af430e6c166855
Autor:
E Evgen'evna Chazova, T V Martyniuk
Publikováno v:
Системные гипертензии, Vol 12, Iss 2, Pp 71-82 (2015)
On behalf of the group of russian researchers. The aim of the VICTORY study was to estimate the efficacy and safety of valsartan monotherapy using different dose regimes (Valsacor® 80, 160, 320 mg) and its fixed combination with hydrochlorothiazide
Externí odkaz:
https://doaj.org/article/c1f3f85961e5491fa8254d3fea37e9aa